|
Zygomycosis in a general hospital during a 17-year period. Is there an increase in
incidence after introducing voriconazole? (click for details) |
|
|
|
Is terbinafine a good antifungal drug to combine with voriconazole or
caspofungin? Study of the activity of double combinations against invasive
clinical isolates of A. fumigatus (click for details) |
|
|
|
Risk factors for invasive aspergillosis in haematologic malignancy patients in a
tertiary teaching hospital in Korea (click for details) |
|
|
|
Monitoring of voriconazole blood levels for prevention of serious neurological
adverse events (click for details) |
|
|
|
Isolation of Rhizopus microsporus varietasmicrosporus from urine in patient with
renal mucormycosis (click for details) |
|
|
|
Aspergillus fumigatus infections in patients with chronic granulomatous disease
hospitalised in a children's memorial health institute, Warsaw, Poland (click for details) |
|
|
|
Evaluation of a rapid colorimetric test based on trehalose use for identification of
Candida glabrata (click for details) |
|
|
|
Candida embolic stroke and secondary fungal mycotic aneurysm (click for details) |
|
|
|
Ability of Spanish clinical laboratories in diagnosing Candida krusei infections
and in monitoring susceptibility testing. Results of the SEIMC Quality Control
Program (click for details) |
|
|
|
Fungaemia at a tertiary-care hospital: species distribution, antifungal
susceptibility and antifungal therapy (click for details) |
|
|
